Novartis cannot block drugmaker MSN Pharmaceuticals from launching a generic version of its blockbuster heart-failure drug ...

Johnson & Johnson convinced a U.S. appeals court on Tuesday to reject a bid from generic drugmakers Teva and Viatris to ...

Damson Idris is quickly emerging as one of Hollywood’s most promising young stars working today. The British-born actor has ...

Far from the triumphant return to form DC and Warner Bros hoped for, James Gunn's 'Superman' is a generic, dull, overwritten ...

A Delaware federal judge has ruled that Novartis cannot prevent MSN Pharmaceuticals from introducing a generic version of its ...

Wockhardt will exit its loss-making US generic business to focus on antibiotics and diabetes care. The company filed for ...

The state law gives Gov. Lamont "an enormous amount of negotiating leverage with the industry," Sen. Lesser said.

The state law gives Gov. Lamont "an enormous amount of negotiating leverage with the industry," Sen. Lesser said.

Wockhardt Ltd on July 11 said it has decided to exit US generic pharmaceutical segment to unlock capital for high-impact ...

U.S. telehealth upstart Hims & Hers Health, Inc. is planning to enter the Canadian market with an eye to selling generic ...

This multi-state settlement addresses makers of generic versions of opioids and is up to $720 million, officials said.

Indian drug firm Wockhardt announces exit from its loss-incurring US generic business to concentrate on innovative ...